MedPath

Counterconditioning as treatment for chronic pain symptoms: a pilot study

Completed
Conditions
Fibromyalgie
chronic widespread pain
Fibromyalgia
Registration Number
NL-OMON55456
Lead Sponsor
niversiteit Leiden
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
17
Inclusion Criteria

Diagnosis of fibromyalgia (provided by GP or medical specialist)
Current pain symptoms because of fibromyalgia
>= 18 years old female
Good understanding of written and spoken Dutch

Exclusion Criteria

Physical conditions other than fibromyalgia explaining pain symptoms;
Psychiatric conditions not related to the fibromyalgia symptoms (e.g.,
schizophrenia);
Pregnancy or lactation;
Refusal to remove artificial nails, nail polish, or any other substance
covering the thumbnail;
Having metal-containing implants in the non-dominant arm (including
non-removable piercings);
Carrying a pacemaker or implanted pumps;
Injuries/open wounds on the non-dominant arm
Not being able to clearly distinguish between three different pressure pain
intensities during testing

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main study parameter will be the feasibility of the counterconditioning<br /><br>intervention. This will be done by looking at the drop-out rate, by measuring<br /><br>participant*s satisfaction with the intervention; by examing what, according to<br /><br>the participants, is causing the possible increase and reduction of<br /><br>experimentally evoked pressure pain in the test phase of (counter)conditioning<br /><br>(e.g., the TENS device, the placebo or nocebo effect); by exploring the amount<br /><br>of experimentally-evoked pressure pain reported during the test phase of<br /><br>counterconditioning, whether this reduces over time, as well as the speed of<br /><br>this reduction.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Not applicable.</p><br>
© Copyright 2025. All Rights Reserved by MedPath